Correction: Risk-Scoring Model for Prediction of Non-Home Discharge in Epithelial Ovarian Cancer Patients (Journal of the American College of Surgeons (2013) 2017 (3)(507–515) (S1072751513003530) (10.1016/j.jamcollsurg.2013.04.036));Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patients

Journal of the American College of Surgeons

Volumn 217, Issue 3, 2013, Pages 507-515

  Alhilli, Mariam M ^a   Tran, Christine W ^a   Langstraat, Carrie L ^a   Martin, Janice R ^a   Weaver, Amy L ^a   McGree, Michaela E ^a   Mariani, Andrea ^a   Cliby, William A ^a   Bakkum Gamez, Jamie N ^a  

^a MAYO CLINIC   (United States)

Author keywords

American Society of Anesthesiologists; ASA; Eastern Cooperative Oncology Group; ECOG; EOC; epithelial ovarian cancer; interquartile range; IQR; odds ratio; OR; skilled nursing facility; SNF

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEATH; DEMOGRAPHY; HEALTH CARE FACILITY; HOSPICE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PATIENT CARE; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANK SUM TEST; REHABILITATION CENTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 84882909467     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2017.05.011     Document Type: Erratum

References (42)

1. A. Jemal, T. Murray, and E. Ward Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
3. G.D. Aletti, S.C. Dowdy, and K.C. Podratz Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer Am J Obstet Gynecol 197 2007 676.e1 676.e7
4. G.D. Aletti, E.L. Eisenhauer, and A. Santillan Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment Gynecol Oncol 120 2011 23 28
5. R. Yancik Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality Cancer 71 1993 517 523
6. C. Langstraat, G.D. Aletti, and W.A. Cliby Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization Gynecol Oncol 123 2011 187 191
7. D.S. Alberts, S. Dahlberg, and S.J. Green Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study Cancer 71 1993 618 627
8. N.G. Cloven, A. Manetta, and M.L. Berman Management of ovarian cancer in patients older than 80 years of age Gynecol Oncol 73 1999 137 139
9. F.E. Turrentine, H. Wang, and V.B. Simpson Surgical risk factors, morbidity, and mortality in elderly patients J Am Coll Surg 203 2006 865 877
10. K.N. Moore, M.S. Reid, and D.N. Fong Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Gynecol Oncol 110 2008 133 139
11. M. Janda, D.R. Youlden, and P.D. Baade Elderly patients with stage III or IV ovarian cancer: should they receive standard care? Int J Gynecol Cancer 18 2008 896 907
12. G.D. Aletti, A. Santillan, and E.L. Eisenhauer A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model Gynecol Oncol 107 2007 99 106
13. S. Sharma, D. Driscoll, and K. Odunsi Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients Am J Obstet Gynecol 193 2005 2077 2082
14. K.A. McLean, C.A. Shah, and S.A. Thompson Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction Gynecol Oncol 118 2010 43 46
15. M.A. Makary, D.L. Segev, and P.J. Pronovost Frailty as a predictor of surgical outcomes in older patients J Am Coll Surg 210 2010 901 908
16. J.S. Partridge, D. Harari, and J.K. Dhesi Frailty in the older surgical patient: a review Age Ageing 41 2012 142 147
17. M. Courtney-Brooks, and A.R. Tellawi Frailty: an outcome predictor for elderly gynecologic oncology patients Gynecol Oncol 126 2012 20 24
18. J. Zabora, K. BrintzenhofeSzoc, and B. Curbow The prevalence of psychological distress by cancer site Psychooncology 10 2001 19 28
19. G.L. Jones, W. Ledger, and T.J. Bonnett The impact of treatment for gynecological cancer on health-related quality of life (HRQoL): a systematic review Am J Obstet Gynecol 194 2006 26 42
20. L. Wenzel, H.Q. Huang, and B.J. Monk Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study J Clin Oncol 23 2005 5605 5612
21. T.N. Robinson, J.I. Wallace, and D.S. Wu Accumulated frailty characteristics predict postoperative discharge institutionalization in the geriatric patient J Am Coll Surg 213 2011 37 42 discussion 42-44
22. V.J. Legner, N.N. Massarweh, and R.G. Symons The significance of discharge to skilled care after abdominopelvic surgery in older adults Ann Surg 249 2009 250 255
23. T.N. Robinson, D.S. Wu, and G.V. Stiegmann Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults Am J Surg 202 2011 511 514
24. W. Max, D.P. Rice, and H.Y. Sung The economic burden of gynecologic cancers in California, 1998 Gynecol Oncol 88 2003 96 103
25. W.K. Barsoum, T.G. Murray, and A.K. Klika Predicting patient discharge disposition after total joint arthroplasty in the United States J Arthroplasty 25 2010 885 892
26. G. Pattakos, D.R. Johnston, and P.L. Houghtaling Preoperative prediction of non-home discharge: a strategy to reduce resource use after cardiac surgery J Am Coll Surg 214 2012 140 147
27. Eastern Cooperative Oncology Group. ECOg performance status. Available at: http://www.ecog.org/general/perf-stat.html. Accessed October 22, 2012.
28. C. Kamby, and L. Sengelov Assessment of functional status in patients with invasive carcinoma of the urothelial tract Urol Oncol 2 1996 43 51
29. J.N. Bakkum-Gamez, C.L. Langstraat, and J.R. Martin Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma Gynecol Oncol 125 2012 614 620
30. R. Yancik, L.G. Ries, and J.W. Yates Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data Am J Obstet Gynecol 154 1986 639 647
31. D. Uyar, H.E. Frasure, and M. Markman Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer Gynecol Oncol 98 2005 403 408
32. L.A. Ries Ovarian cancer. Survival and treatment differences by age Cancer 71 1993 524 529
33. C.D. O'Malley, S.J. Shema, and R.D. Cress The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a centers for disease control and prevention study J Womens Health (Larchmt) 21 2012 887 894
34. J.K. Chan, M.K. Cheung, and A. Husain Patterns and progress in ovarian cancer over 14 years Obstet Gynecol 108 2006 521 528
35. C.D. O'Malley, R.D. Cress, and S.L. Campleman Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study Gynecol Oncol 91 2003 608 615
36. M.A. Aghazadeh, D.A. Barocas, and S. Salem Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort J Urol 185 2011 85 89
37. L.B. Oldmeadow, H. McBurney, and V.J. Robertson Targeted postoperative care improves discharge outcome after hip or knee arthroplasty Arch Phys Med Rehab 85 2004 1424 1427
38. D.M. Kelly, R. Bennett, and N. Brown Predicting the discharge status after liver transplantation at a single center: a new approach for a new era Liver Transpl 18 2012 796 802
39. K. Touijer, and P.T. Scardino Nomograms for staging, prognosis, and predicting treatment outcomes Cancer 115 2009 3107 3111
40. I.J. Nixon, I. Ganly, and L.E. Hann Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features Surgery 148 2010 1120 1127 discussion 1127-1128
41. D.S. Chi, M.J. Palayekar, and Y. Sonoda Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma Gynecol Oncol 108 2008 191 194
42. J.N. Barlin, C. Yu, and E.K. Hill Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer Gynecol Oncol 125 2012 25 30